The Alive Study: A Longitudinal Study of HIV-1 Infection in Intravenous Drug Users: Description of Methods

David Vlahov; James C. Anthony; Alvaro Muñoz; Joseph Margolick; Kenrad E. Nelson; David D. Celentano; Liza Solomon; B. Frank Polk

doi:10.1177/002204269102100406

The Alive Study: A Longitudinal Study of HIV-1 Infection in Intravenous Drug Users: Description of Methods

David Vlahov, James C. Anthony, Alvaro Muñoz, Joseph Margolick, Kenrad E. Nelson, David D. Celentano, Liza Solomon, B. Frank Polk

Bloomberg School of Public Health

Research output: Contribution to journal › Article › peer-review

135 Scopus citations

Abstract

To identify risk factors for infection with the human immunodeficiency virus (HIV) and for progression to the acquired immunodeficiency syndrome (AIDS) among intravenous drug users, we established a cohort in Baltimore Maryland in 1988–1989. Intravenous drug users were recruited by extensive community outreach to undergo interview and confidential HIV testing in a special study site. During 13 months of recruitment, 2,921 intravenous drug users were enrolled of whome 24 percent were HIV seropositive; 90 percent returned to receive test results. Methodological issues for enhancing recruitment and retention of drug users are discussed.

Original language	English (US)
Pages (from-to)	759-776
Number of pages	18
Journal	Journal of Drug Issues
Volume	21
Issue number	4
DOIs	https://doi.org/10.1177/002204269102100406
State	Published - Oct 1991

ASJC Scopus subject areas

Medicine (miscellaneous)
Health(social science)
Public Health, Environmental and Occupational Health
Psychiatry and Mental health

Access to Document

10.1177/002204269102100406

Cite this

@article{578c3ddd0b674104b1e048a8bad54d8c,

title = "The Alive Study: A Longitudinal Study of HIV-1 Infection in Intravenous Drug Users: Description of Methods",

abstract = "To identify risk factors for infection with the human immunodeficiency virus (HIV) and for progression to the acquired immunodeficiency syndrome (AIDS) among intravenous drug users, we established a cohort in Baltimore Maryland in 1988–1989. Intravenous drug users were recruited by extensive community outreach to undergo interview and confidential HIV testing in a special study site. During 13 months of recruitment, 2,921 intravenous drug users were enrolled of whome 24 percent were HIV seropositive; 90 percent returned to receive test results. Methodological issues for enhancing recruitment and retention of drug users are discussed.",

author = "David Vlahov and Anthony, {James C.} and Alvaro Mu{\~n}oz and Joseph Margolick and Nelson, {Kenrad E.} and Celentano, {David D.} and Liza Solomon and Polk, {B. Frank}",

year = "1991",

month = oct,

doi = "10.1177/002204269102100406",

language = "English (US)",

volume = "21",

pages = "759--776",

journal = "Journal of Drug Issues",

issn = "0022-0426",

publisher = "Journal of Drug Issues Inc.",

number = "4",

}

TY - JOUR

T1 - The Alive Study

T2 - A Longitudinal Study of HIV-1 Infection in Intravenous Drug Users: Description of Methods

AU - Vlahov, David

AU - Anthony, James C.

AU - Muñoz, Alvaro

AU - Margolick, Joseph

AU - Nelson, Kenrad E.

AU - Celentano, David D.

AU - Solomon, Liza

AU - Polk, B. Frank

PY - 1991/10

Y1 - 1991/10

N2 - To identify risk factors for infection with the human immunodeficiency virus (HIV) and for progression to the acquired immunodeficiency syndrome (AIDS) among intravenous drug users, we established a cohort in Baltimore Maryland in 1988–1989. Intravenous drug users were recruited by extensive community outreach to undergo interview and confidential HIV testing in a special study site. During 13 months of recruitment, 2,921 intravenous drug users were enrolled of whome 24 percent were HIV seropositive; 90 percent returned to receive test results. Methodological issues for enhancing recruitment and retention of drug users are discussed.

AB - To identify risk factors for infection with the human immunodeficiency virus (HIV) and for progression to the acquired immunodeficiency syndrome (AIDS) among intravenous drug users, we established a cohort in Baltimore Maryland in 1988–1989. Intravenous drug users were recruited by extensive community outreach to undergo interview and confidential HIV testing in a special study site. During 13 months of recruitment, 2,921 intravenous drug users were enrolled of whome 24 percent were HIV seropositive; 90 percent returned to receive test results. Methodological issues for enhancing recruitment and retention of drug users are discussed.

UR - http://www.scopus.com/inward/record.url?scp=0026348264&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026348264&partnerID=8YFLogxK

U2 - 10.1177/002204269102100406

DO - 10.1177/002204269102100406

M3 - Article

AN - SCOPUS:0026348264

SN - 0022-0426

VL - 21

SP - 759

EP - 776

JO - Journal of Drug Issues

JF - Journal of Drug Issues

IS - 4

ER -

The Alive Study: A Longitudinal Study of HIV-1 Infection in Intravenous Drug Users: Description of Methods

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this